Abstract
The aim of the present investigations was to study the influence of increasing age on the pharmacodynamics of valproate in BN/BiRij rats, applying a threshold for electrically induced localized seizure activity as a measure of the anticonvulsant effect. Seven groups of healthy male BN/BiRij rats were used, aged 3, 6, 12, 19, 25, 31, and 37 months. Individual plasma concentration versus anticonvulsant effect relationships were determined during a continuous intravenous infusion of sodium valproate at a rate of 5.5 mg/min/kg. The infusion was terminated when the anticonvulsant effect intensity had reached the maximum attainable level or at a total infusion time of three hours. A nonlinear relationship between valproate concentration and anticonvulsant effect intensity was observed with no maximal effect in the concentration range up to 1200 mg · L−1. With increasing age a parallel shift in the concentration versus anticonvulsant effect relationships toward lower concentrations occurred. Thus increasing age appears to be associated with an increased sensitivity to the anticonvulsant effect of valproate.
Similar content being viewed by others
REFERENCES
E. Perucca, R. Grimaldi, G. Gatti, S. Pirracchio, F. Crema, and G. M. Frigo. Pharmacokinetics of valproic acid in the elderly. Br. J. Clin. Pharmacol. 17:665–669 (1984).
Editorial: Sodium valproate and the liver. Lancet 2:1119–1120 (1980).
E. S. Zafrani and P. Berthelot. Sodium valproate in the induction of unusual hepatotoxicity. Hepatology 2:648–649 (1982).
C. A. Williams, S. Tiefenbach, and J. W. McReynolds. Valproic acid-induced hyperammonemia in mentally retarded adults. Neurology 34:550–553 (1984).
S. M. Bryson, N. Verma, P. J. W. Scott, and P. C. Rubin. Pharmacokinetics of valproic acid in young and elderly subjects. Br. J. Clin. Pharmacol. 16:104–105 (1983).
L. A. Bauer, R. Davis, A. Wilensky, V. Raisys, and R. H. Levy. Valproic acid clearance: Unbound fraction and diurnal variation in young and elderly adults. Clin. Pharmacol. Ther. 37:697–700 (1985).
K. Hall, N. Otten, B. Johnston, J. Irvine-Meek, M. Leroux, and S. Seshia. A multivariable analysis of factors governing the steady-state pharmacokinetics of valproic acid in 52 young epileptics. J. Clin. Pharmacol. 25:261–268 (1985).
H. Y. Yu, Y. Sugiyama, and M. Hanano. Changes in pharmacokinetics of valproic acid in guinea pigs from birth to maturity. Epilepsia 26:243–251 (1985).
J. W. Van der Laan, T. De Boer, and J. Bruinvels. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase. J. Neurochem. 32:1769–1780 (1979).
R. Monteleone, M. Iovino, F. Orio, and L. Steardo. Impaired growth hormone response to sodium valproate in normal aging. Psychopharmacology 91:10–13 (1987).
R. A. Voskuyl, J. Dingemanse, and M. Danhof. Determination of the threshold for convulsions by direct cortical stimulation. Epilepsy Res. 3:120–129 (1989).
A. M. Stijnen, M. Danhof, and C. F. A. van Bezooijen. Increased sensitivity to the anesthetic effect of phenobarbital in rats. J. Pharmacol. Exp. Ther. 261:81–87 (1992).
J. Dingemanse, R. A. Voskuyl, M. W. E. Langemeijer, I. Postel-Westra, D. D. Breimer, H. Meinardi, and M. Danhof. Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats. Br. J. Pharmacol. 99:53–58 (1990).
R. A. Voskuyl, A. Hoogerkamp, and M. Danhof. Properties of the convulsive threshold determined by direct cortical stimulation in rats. Epilepsy Rats. 12:111–120 (1992).
W. Löscher and H. Siemes. Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children. Lancet 2:225 (1984).
S. Liljequist and J. A. Engel. Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists. Life Sci. 34:2525–2533 (1984).
G. Racagni, J. A. Apud, D. Cocchi, V. Locatelli, and E. E. Müller. GABAergic control of anterior pituitary hormone secretion. Life Sci. 31:823–838 (1982).
W. Löscher, C. P. Fassbender, and B. Nolting. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. Epilepsy Res. 8:79–94 (1991).
W. Kamphuis and F. H. L. Da Silva. The kindling model of epilepsy: the role of GABA-ergic inhibition. Neurosci. Res. Commun. 6:1–10 (1990).
A. Chapman, P. E. Keane, B. S. Meldrum, J. Simiand, and J. C. Vernieres. Mechanism of anticonvulsant action of valproate. Prog. Neurobiol. 19:315–359 (1982).
M. J. Eadie. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance. Clin. Pharmacokin. 21:27–41 (1991).
J. Li, D. L. Norwood, L.-F. Mao, and H. Schulz. Mitochondrial metabolism of valproic acid. Biochemistry 30:388–394 (1991).
K. Kitani, Y. Masuda, Y. Sato, S. Kanai, M. Ohta, and M. Nokubo. Increased anticonvulsant effect of phenytoin in aging BDF1 mice. J. Pharmacol. Exp. Ther. 229:231–236 (1984).
K. Kitani, Y. Sato, S. Kanai, M. Nokubo, M. Ohta, and Y. Masuda. Increased anticonvulsant effect of phenobarbital with age in mice—a possible pharmacological index for brain aging. Life Sci. 37:1451–1460 (1985).
K. Kitani, Y. Sato, S. Kanai, M. Nokubo, M. Ohta, and Y. Masuda. Increased anticonvulsant effect of AD-810 (zonisamide) in aging BDF1 mice. Life Sci. 41:1339–1344 (1987).
K. Kitani, Y. Sato, S. Kanai, M. Ohta, M. Nokubo, and Y. Masuda. The neurotoxicity of phenobarbital and its effect in preventing pentylenetetrazol-induced maximal seizure in aging mice. Arch. Geront. Geriat. 7:261–271 (1988).
K. Kitani, U. Klotz, S. Kanai, Y. Sato, M. Ohta, and M. Nokubo. Age-related differences in the coordination disturbance and anticonvulsant effect of oxazepam in mice. Arch. Geront. Geriat. 9:31–43 (1989).
Author information
Authors and Affiliations
Additional information
Suzanne Hovinga: Deceased January 30, 1991.
Rights and permissions
About this article
Cite this article
Stijnen, A.M., Hovinga, S., Langemeijer, M.W.E. et al. Increased Sensitivity to the Anticonvulsant Effect of Valproate in Aging BN/BiRij Rats. Pharm Res 10, 1046–1051 (1993). https://doi.org/10.1023/A:1018975025417
Issue Date:
DOI: https://doi.org/10.1023/A:1018975025417